NVision Selected for EuroHPC Quantum Grand Challenge With Spin-Qubit Project

Understand this faster with AI
Insider BriefPRESS RELEASE — The EuroHPC Joint Undertaking has selected NVision Quantum Technologies as one of 13 companies to receive funding under its Quantum Grand Challenge, an EU program aimed at helping Europe turn its strength in quantum research into industrial-scale, commercially competitive technologies. Of the three German companies selected, NVision is the only one pursuing a spin-qubit architecture.Building on its expertise in controlling quantum spins in organic molecules, NVision has developed PIQC, a photon-interfaced spin-qubit architecture, combining the performance advantages of spin qubits with the unique connectivity of photonics. While conventional spin-qubit approaches typically rely on local interactions between neighboring qubits, PIQC is designed to connect qubits through photonic integrated circuits, providing a path toward chip-integrated, modular systems with all-to-all connectivity.“Europe has the science, talent and industrial capabilities to lead in quantum computing. The challenge now is to turn those strengths into quantum systems that can actually scale, be manufactured and compete globally,” said Dr. Sella Brosh, CEO and Co-Founder of NVision Quantum Technologies. “As we see it today, photonic connectivity is the only viable path to scaling quantum computers to the size required for fault-tolerant operation. That is why we built connectivity into our architecture from the outset, rather than treating it as a problem to solve later. This selection is an important step toward turning that architecture into a scalable, fault-tolerant quantum computing platform that can be built and manufactured in Europe.” Through QOSMOS, short for “Quantum Computers based on Spin Qubits in Organic Molecules,” NVision will develop the technical and financial roadmap for scaling PIQC toward an integrated, error-corrected quantum computing platform. The four-month project will benchmark the current technology, define hardware, software and integration milestones, and explore high-value applications with an initial focus on quantum simulation for chemistry and pharmaceutical research. The architecture is designed to integrate with established photonic and semiconductor manufacturing technologies and, in the future, operate alongside European high-performance computing infrastructure.The Quantum Grand Challenge is designed to help promising European quantum technologies move from scientific development toward industrial-scale systems. Phase 1 supports selected companies in developing the technical and financial roadmaps needed for scale-up. The most promising projects can then apply for long-term venture debt financing from the European Investment Bank to support the next stage of commercial and industrial development.EuroHPC’s Governing Board approved the selected projects on June 19, 2026 (Decision No. 31/2026) following an independent evaluation process. Thirty proposals were submitted, with 13 projects selected for funding on the main list and three placed on a reserve list.QOSMOS will receive €293,455 in EU funding for its four-month Phase 1 project once the grant agreement, currently in preparation, is signed.TopicsShare Get the latest research, company news, and market intelligence every week. MENTIONED IN THE ARTICLENVision Imaging Technologies is developing POLARIS, a quantum-enhanced metabolic MRI platform that provides rapid, safe, and affordable imaging of cellular metabolism using standard MRI machines.More in Research The Quantum Insider (TQI) is the leading source for the latest quantum technology news, market intelligence, industry analysis, and data covering the global quantum ecosystem. NEWSROOMPLATFORMSERVICESCOMPANY© 2026 The Quantum Insider. All rights reserved. Part of the Resonance networkOne of our team will be in touch to learn more about your requirements, and provide pricing and access options.Subscribe to our industry leading leading newsletter for the latest in quantum news and insights. Necessary cookies are always on to ensure the website works. Optional cookies help us understand how the site is used. Privacy Policy
Tags
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
